Application of PRKCZ autoantibody detection reagent in preparation of lung cancer screening kit
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- WEST CHINA HOSPITAL SICHUAN UNIV
- Publication Date
- 2019-11-15
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of in vitro diagnostic reagents, in particular to the use of PRKCZ autoantibody detection reagents in the preparation of lung cancer screening kits. Background technique
[0002] Lung cancer is one of the most common malignant tumors in the world. Its morbidity and mortality are increasing year by year. Currently, the incidence rate ranks first in the world, which seriously threatens human health and life.
[0003] Lung cancer is a disease that is good at concealment. It often shows clinical symptoms when the disease develops to an advanced stage. 70-80% of lung cancer patients are already in the middle or late stage when they are diagnosed with lung cancer symptoms. The best cure time, five-year survival rate is low. For patients with early lung cancer, timely treatment can greatly improve the 5-year survival rate and quality of life of the patients. Therefore, early diagnosis and effective screening of lung cancer...